Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effecters of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells
Ka. Fitzgerald et al., Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effecters of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells, J IMMUNOL, 164(4), 2000, pp. 2053-2063
We have investigated the ability of hyaluronic acid (HA) fragments to activ
ate the transcription factor NF-kappa B, HA fragments activated NF-kappa B
in the cell lines T-24, HeLa, MCF7, and J774, Further studies in T-24 cells
demonstrated that HA fragments also induced I kappa B alpha phosphorylatio
n and degradation, kappa B-linked reporter gene expression, and ICAM-1 prom
oter activity in an NF kappa B-dependent manner. The effect of HA was size
dependent as neither disaccharide nor native HA were active. CD44, the prin
cipal cellular receptor for HA, was critical for the response because the a
nti-CD44 Ab IM7.8.1 blocked the effect on NF-kappa B, HA fragments activate
d the I kappa B kinase complex, and the effect on a kappa B-linked reporter
gene was blocked in T-24 cells expressing dominant negative I kappa B kina
ses 1 or 2. Activation of protein kinase C (PKC) was required because calph
ostin C inhibited NF-kappa B activation and I kappa B alpha phosphorylation
, In particular, PKC zeta was required because transfection of cells with d
ominant negative PKC zeta blocked the effect of HA fragments on kappa B-lin
ked gene expression and HA fragments increased PKC zeta activity. Furthermo
re, damnacanthal and manumycin A, two mechanistically distinct inhibitors o
f Ras, blocked NF-kappa B activation, Transfection of T-24 cells with domin
ant negative Ras (RasN17) blocked HA fragment-induced kappa B-linked report
er gene expression, and HA fragments activated Ras activity within 5 min. T
aken together, these studies establish a novel signal transduction cascade
eminating from CD44 to pas, PKC zeta, and I kappa B kinase 1 and 2, The Jou
rnal of Immunology, 2000, 164: 2053-2063.